Press Releases

BioMS Medical Corp Announces Warrant Extension

Edmonton, Alberta, October 13, 2004 - BioMS Medical Corp (TSX: MS) announces that effective on Thursday, October 21, 2004, the term of share purchase warrants (the “Warrants”) issued by BioMS, entitling the holders thereof to purchase up to 1,815,000 Class A common shares at a price of $4.00 per share on or before October 22, 2004, has been extended from October 22, 2004 to October 22, 2005.

BioMS has received undertakings from insiders of BioMS who hold a total of 9,400 Warrants that they will not exercise the Warrants unless and until approval of disinterested shareholders of BioMS is obtained in accordance with the policies of the Toronto Stock Exchange.

This press release may contain forward-looking statements, which reflect the Corporation’s current expectation regarding future events. These forward-looking statements involve risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Corporation’s ongoing quarterly and annual reporting. Certain of the assumptions made in preparing forward-looking statements include but are not limited to the following: that dirucotide (MBP8298) will continue to demonstrate a satisfactory safety profile in ongoing and future clinical trials; and that BioMS Medical Corp. will complete the respective clinical trials within the timelines communicated in this release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.